Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Bioterrorism: pathogens as weapons.

Anderson PD, Bokor G.

J Pharm Pract. 2012 Oct;25(5):521-9.

PMID:
23011963
2.
3.

Preparing for bioterrorism: category A agents.

Persell DJ, Arangie P, Young C, Stokes EN, Payne WC, Skorga P, Gilbert-Palmer D.

Nurse Pract. 2001 Dec;26(12):12-5, 19-24, 27; quiz 28-9. Review.

PMID:
11809039
4.

Bioterrorism: management of major biological agents.

Bossi P, Garin D, Guihot A, Gay F, Crance JM, Debord T, Autran B, Bricaire F.

Cell Mol Life Sci. 2006 Oct;63(19-20):2196-212. Review.

PMID:
16964582
5.

[Practical strategies against bioterrorism].

Matsumoto T.

Nihon Rinsho. 2007 Dec;65(12):2363-73. Review. Japanese.

PMID:
18069284
6.

Biowarfare and bioterrorism.

Christian MD.

Crit Care Clin. 2013 Jul;29(3):717-56. doi: 10.1016/j.ccc.2013.03.015. Review.

PMID:
23830660
7.

Bacterial pathogens as biological weapons and agents of bioterrorism.

Greenfield RA, Drevets DA, Machado LJ, Voskuhl GW, Cornea P, Bronze MS.

Am J Med Sci. 2002 Jun;323(6):299-315. Review.

PMID:
12074485
8.

[Germs and toxins in bioterrorism].

Inoue N.

Nihon Rinsho. 2003 Feb;61 Suppl 2:81-91. Review. Japanese. No abstract available.

PMID:
12722194
9.

The threat of biological terrorism: a public health and infection control reality.

Leggiadro RJ.

Infect Control Hosp Epidemiol. 2000 Jan;21(1):53-6. Review.

PMID:
10656359
10.

Medical management of biological warfare and bioterrorism: place of the immunoprevention and the immunotherapy.

Binder P, Attre O, Boutin JP, Cavallo JD, Debord T, Jouan A, Vidal D.

Comp Immunol Microbiol Infect Dis. 2003 Oct;26(5-6):401-21. Review.

PMID:
12818625
11.

The threat of bioterrorism: a reason to learn more about anthrax and smallpox.

Gordon SM.

Cleve Clin J Med. 1999 Nov-Dec;66(10):592-5, 599-600. Review.

PMID:
10598363
12.

Bacterial agents used for bioterrorism.

Horn JK.

Surg Infect (Larchmt). 2003 Fall;4(3):281-7. Review.

PMID:
14588163
13.

Recognition and management of bioterrorism infections.

O'Brien KK, Higdon ML, Halverson JJ.

Am Fam Physician. 2003 May 1;67(9):1927-34. Review.

14.

Bioterrorism.

Steinhauer R.

RN. 2002 Mar;65(3):48-54; quiz 55. Review. No abstract available.

PMID:
11961869
15.

[Biological weapons].

Kerwat K, Becker S, Wulf H, Densow D.

Dtsch Med Wochenschr. 2010 Aug;135(33):1612-6. doi: 10.1055/s-0030-1262454. Epub 2010 Aug 17. Review. German.

PMID:
20717866
16.

[Diseases caused by bacteria and rickettsia in biological warfare and bioterrorism].

Bojić I, Vukadinov J, Minić S.

Med Pregl. 2007 Mar-Apr;60(3-4):195-7. Review. Serbian.

PMID:
17853736
17.

Vaccines for Category A bioterrorism diseases.

Lutwick LI, Nierengarten MB.

Expert Opin Biol Ther. 2002 Dec;2(8):883-93. Review.

PMID:
12517267
18.

Histopathology and immunohistochemistry in the diagnosis of bioterrorism agents.

Guarner J, Zaki SR.

J Histochem Cytochem. 2006 Jan;54(1):3-11. Epub 2005 Sep 7. Review.

PMID:
16148309
19.

Bioterrorism. Clinical recognition and primary management.

Branda JA, Ruoff K.

Am J Clin Pathol. 2002 Jun;117 Suppl:S116-23. Review.

PMID:
14569808
20.

Antibiotic selection and resistance issues with fluoroquinolones and doxycycline against bioterrorism agents.

Brouillard JE, Terriff CM, Tofan A, Garrison MW.

Pharmacotherapy. 2006 Jan;26(1):3-14. Review.

PMID:
16506347

Supplemental Content

Support Center